Search all medical codes

Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), qualitative RT-PCR, nasopharyngeal swab, each pathogen rep

CPT4 code

Name of the Procedure:

Infectious Disease Screening for Respiratory Pathogens, Qualitative RT-PCR Test

Summary

This test is a diagnostic procedure that detects genetic material (DNA or RNA) from multiple respiratory pathogens, including the virus responsible for COVID-19, using a sample from a nasopharyngeal swab. It specifically targets 22 different pathogens to determine the cause of respiratory infections.

Purpose

This procedure aims to identify the specific bacterial or viral pathogen responsible for a respiratory tract infection. The precise identification helps tailor appropriate treatment and management plans, improving patient outcomes.

Indications

This test is indicated for patients showing symptoms of a respiratory infection, such as fever, cough, shortness of breath, or sore throat. It is particularly used in cases where the specific pathogen needs to be identified for targeted treatment.

Preparation

  • No special preparation is required.
  • Patients should inform their healthcare provider about any medications they are currently taking.

Procedure Description

  1. A healthcare provider will insert a thin swab into the patient's nostril, reaching the nasopharynx.
  2. The swab is gently rotated to collect a sample of respiratory secretions.
  3. The sample is then sent to a laboratory where it undergoes qualitative RT-PCR (reverse transcription polymerase chain reaction) testing to detect genetic material from 22 respiratory pathogens, including SARS-CoV-2.
  4. No anesthesia or sedation is required for this procedure.

Duration

The swabbing procedure itself takes less than a minute. The test results typically take a few hours to a few days, depending on the lab processing time.

Setting

The procedure is usually performed in an outpatient clinic, doctor's office, or hospital setting.

Personnel

The procedure is conducted by trained healthcare professionals such as nurses or medical technicians.

Risks and Complications

  • Common: Mild discomfort or gagging during the swab collection.
  • Rare: Minor bleeding or irritation at the swab site.
  • Complications are extremely rare and usually minor.

Benefits

  • Accurate identification of the respiratory pathogen.
  • Helps in choosing the most effective treatment.
  • Reduces the risk of unnecessary antibiotics or antiviral agents.

Recovery

  • No specific recovery time is required.
  • Patients can resume normal activities immediately after the procedure.

Alternatives

  • Other diagnostic tests for respiratory infections, such as antigen tests, blood tests, or chest X-rays.
  • Pros of RT-PCR: Higher accuracy and specificity compared to some other tests.
  • Cons: May take longer to get results compared to rapid antigen tests.

Patient Experience

  • The patient might feel mild discomfort or gagging during the swab.
  • The swab collection process is quick, and discomfort is brief.
  • Pain management is typically not necessary, but patients can speak with their healthcare provider about any concerns.

By providing detailed information on the procedure, patients can be better prepared and feel more at ease when undergoing this important diagnostic test.

Medical Policies and Guidelines for Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), qualitative RT-PCR, nasopharyngeal swab, each pathogen rep

Related policies from health plans

Similar Codes